| 551 |
MOLOTINIB |
MOMELOTINIB 150 MG |
FILM COATED TABLET |
Bottle |
FOR THE TREATMENT OF INTERMEDIATE OR HIGH RISK MYELOFIBROSIS, INCLUDING PRIMARY MF OR SECONDARY MF POST POLYCYTHEMIA VERA AND POST ESSENTIAL THROMBOCYTHEMIA IN ADULT WITH ANEMIA |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
10 L 1219/24 |
2024-10-31 |
2029-10-30 |
View |
| 552 |
ODXIBAT |
ODEVIXIBAT 0.2 MG |
CAPSULE |
BOTTLE |
USED TO TREAT PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS IN PATIENTS AGED 6 MONTHS OR OLDER |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
09 L 1190/24 |
2024-09-24 |
2027-09-23 |
View |
| 553 |
ODXIBAT |
ODEVIXIBAT 1.2 MG |
CAPSULE |
BOTTLE |
USED TO TREAT PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS IN PATIENTS AGED 6 MONTHS OR OLDER |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
09 L 1189/24 |
2024-09-24 |
2027-09-23 |
View |
| 554 |
SEMAGLUTIDE |
SEMAGLUTIDE 7 MG |
TABLET |
BOTTLE |
TREATMENT OF TYPE 2 DIABETES MELLITUS |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
08 L 1179/24 |
2024-08-21 |
2027-08-20 |
View |
| 555 |
SEMAGLUTIDE |
SEMAGLUTIDE 14 MG |
TABLET |
BOTTLE |
TREATMENT OF TYPE 2 DIABETES MELLITUS |
No |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
08 L 1178/24 |
2024-08-21 |
2027-08-20 |
View |
| 556 |
METFORWAN XR 500 |
METFORMIN HYDROCHLORIDE USP 500 MG |
EXTENED RELEASE TABLET |
ALU-ALU BLISTER PACK |
TREATMENT OF TYPE 2 DIABETES ME;;ITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL |
Yes |
DKSH LAOS COMPANY LIMITED |
ARGON REMEDIES PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5668/24 |
2024-01-26 |
2027-01-25 |
View |
| 557 |
METHYCOBAL 500 MCG |
MECOBALAMIN 500 MCG |
TABLET |
STRIP |
PERIPHERAL NEUROPATHIES |
No |
DKSH LAOS COMPANY LIMITED |
BUSHU PHARMACEUTICALS LTD. MISATO FACTORY |
THAILAND |
CERTIFICATE RELEASED |
07 I 1920/00 |
2023-03-31 |
2026-03-30 |
View |
| 558 |
METHYCOBAL INJECTION 500 MCG |
MECOBALAMIN JP 500 MCG |
SOLUTION FOR INJECTION |
AMPOULES |
PERIPHERAL NEUROPATHIES, MEGALOBLASTIC ANEMIA DUE TO VITAMIN B12 DEFICIENCY |
No |
DKSH LAOS COMPANY LIMITED |
NIPRO PHARMA CORPORATION ISE PLANT |
JAPAN |
CERTIFICATE RELEASED |
08 I 2946/07 |
2022-09-14 |
2025-09-13 |
View |
| 559 |
METRONIDAZOL KABI |
METRONIDAZOLE 500 MG/100 ML |
SOLUTION FOR INFUSION |
BOTTLE |
TREATMENT OF INFECTION WITH TRICHOMONAS VAGINALIS, ENTAMOEBA HISTOLYCA(ACUTE INTESTINAL INFECTION AND LIVER ABSCESS TYPES), DIENTAMOEBA FRAGILIS IN CHILDREN, GIARDIA LAMBLIA AND DRACUNUNCULUS MEDINENSIS. TREATMENT OF SEVERE INFECTION WITH SUSCEPTIBLE ANAEROBES INCLUDING INTRA-ABDOMINAL INFECTION, GYNECOLOGIC INFECTION, SKIN AND SKIN STRUCTURE INFECTION, CENTRAL NERVOUS SYSTEM INFECTION, BACTERIAL SEPTICEMIA AND ENDOCARDITIS. TREATMENT OF ACUTE NECROTISING ULCERATIVE GINGIVITIS, PERIODONTITIS AND OTHER ANAEROBIC DENTAL INFECTION, ACTIVE CROHN'S DISEASE IN COLON AND RECTAL |
Yes |
DKSH LAOS COMPANY LIMITED |
FRESENIUS KABI VIETNAM JOINT STOCK COMPANY |
VIETNAM |
CERTIFICATE RELEASED |
04 I 5480/23 |
2023-04-25 |
2026-04-24 |
View |
| 560 |
MIRCERA 100 MCG/0.3 ML |
METHOXY POLYETHYLENE GLYCOL EPOETIN BETA.0.100 MG/0.3 ML |
SOLUTION FOR INJECTION |
PRE-FILLED SYRINGE |
FOR THE TREATMENT OF ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE ( CKD ) INCLUDING PATIENTS ON DIALYSIS AND PATIENTS NOT DIALYSIS |
No |
DKSH LAOS COMPANY LIMITED |
F.HOFFMANN-LA ROCHE LTD |
SWITZERLAND |
CERTIFICATE RELEASED |
01 I 3483/11 |
2024-09-25 |
2029-09-24 |
View |
